
Share
A new AI-driven partnership model aims to bridge the gap between advanced technology and tangible patient care improvements, setting a new standard in healthcare.
In a world where healthcare is increasingly intertwined with technology, the launch of a new AI partnership model by Ambience Healthcare marks a significant step forward. This innovative approach not only emphasizes measurable outcomes but also ensures that the benefits of artificial intelligence (AI) are realized at the patient level. As healthcare systems grapple with the integration of cutting-edge technologies, this model could set a new standard for how AI is deployed and evaluated.
Expressable, a leading provider of speech therapy services, has announced its collaboration with Amazon’s Health Benefits Connector, making it the first speech therapy provider on the platform. This partnership pairs patients with licensed, insurance-covered speech therapists for virtual sessions, offering personalized home programs and practice activities to support continuous care. The company reports that 96% of patients across all diagnostic groups make clinical progress within the first five sessions.
Leanne Sherred, Expressable’s president and chief clinical officer, emphasized the importance of early intervention in speech and language development. "A child's early years are a critical window for communication development," she said. "Identifying and supporting a speech or language disorder early can make a meaningful difference in how a child learns, connects, and grows."
Ambience Healthcare’s new partnership model, known as the Ambience Standard, aims to ensure that AI technologies are not just theoretical advancements but practical solutions that improve patient care. The model works directly with healthcare system leadership to identify specific outcomes and targets, deploying teams to structure contracts based on measurable results rather than AI consumption.
Mike Ng, co-founder and president of Ambience Healthcare, explained the rationale behind this approach: "Models don't improve healthcare on their own. It takes the right context, the ability to act inside clinical workflows, rigorous measurement, and people who drive adoption. The Ambience Standard is our commitment to being accountable for the result."
The Ambience Standard is powered by the company’s AI technology platform, Ambience Chorus, which is designed to integrate seamlessly into existing healthcare systems. By focusing on measurable outcomes, Ambience Healthcare aims to address a common criticism of AI in healthcare: the gap between theoretical models and real-world impact. This approach not only ensures that AI technologies are used effectively but also holds providers accountable for their performance.

The model’s emphasis on collaboration with healthcare system leadership is crucial. It involves identifying specific areas where AI can make a difference, such as improving diagnosis accuracy, reducing wait times, or enhancing patient engagement. By aligning these goals with the broader objectives of healthcare organizations, Ambience Healthcare hopes to create a more holistic and effective use of AI.
As the healthcare industry continues to evolve, the integration of AI technologies will play an increasingly important role. The success of models like the Ambience Standard could pave the way for more widespread adoption of AI in clinical settings. However, this also raises concerns about data privacy, cybersecurity, and the potential for bias in AI algorithms.
Recent surveys highlight these concerns, with healthcare IT professionals citing cybersecurity as a top priority. The Fierce Healthcare Fundraising Tracker for 2026 shows significant investments in health tech startups, including Arintra, which secured $25 million, and Happy Health, which raised $75 million. These funds are likely to be directed towards developing more robust AI solutions that address both clinical needs and patient safety.
The future of healthcare IT will depend on striking a balance between innovation and regulation. As new partnerships like the one between Expressable and Amazon’s Health Benefits Connector demonstrate, there is a growing recognition of the need for accessible, personalized care. By focusing on measurable outcomes and accountability, Ambience Healthcare’s model could set a new standard for how AI is deployed in healthcare, ultimately leading to better patient outcomes and more efficient care delivery.
The journey from advanced technology to tangible improvements in patient care is complex but essential. As we move forward, it will be crucial to monitor the impact of these innovations and ensure that they are used ethically and effectively to benefit all patients.
Tags
Original Sources
Weekly Rundown: Expressable joins Amazon's health conditions program; Function launches data connector for AI platforms
↗ https://www.fiercehealthcare.com/health-tech/weekly-rundown-ambience-healthcare-rolls-out-healthcare-ai-partnership-model-function
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
31 August 2026
85 articles
Related Articles

AIDO Cell: The Virtual Model Revolutionizing Our Understanding of Human Cells
Health & Science · 3 min

Eyepoint's Vision Treatment Falters in Key Trial, While Amylyx Sees Success
Health & Science · 4 min

Biotech Firm Akeso Faces Setback as IVONESCIMAB Trial Shows Worsening Tumor Progression
Health & Science · 3 min
Related Articles

AIDO Cell: The Virtual Model Revolutionizing Our Understanding of Human Cells
Health & Science · 3 min

Eyepoint's Vision Treatment Falters in Key Trial, While Amylyx Sees Success
Health & Science · 4 min

Biotech Firm Akeso Faces Setback as IVONESCIMAB Trial Shows Worsening Tumor Progression
Health & Science · 3 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.